Interestingly, we found that the AUC of DCP (PIVKA-II) was performing a little better than that of GALAD (AUROC 0.90 vs. 0.88) for discriminating between HCC and cirrhosis. This evidence concerns the gene ACE and hepatocellular carcinoma.